The expression of BMP, integrin, ZEB2 in ovarian high-grade serous carcinoma in relation with lymph node metastasis

被引:1
|
作者
Zirh, Elham Bahador [1 ,2 ]
Kapakli, Elif Tasar [3 ]
Dolgun, Anil [4 ]
Usubutun, Alp [3 ]
Zeybek, Naciye Dilara [2 ]
机构
[1] TOBB Econ & Technol Univ, Fac Med, Dept Histol & Embryol, Ankara, Turkey
[2] Hacettepe Univ, Fac Med, Dept Histol & Embryol, TR-06100 Ankara, Turkey
[3] Hacettepe Univ, Fac Med, Dept Pathol, Ankara, Turkey
[4] RMIT Univ, Dept Math Sci, Melbourne, Vic, Australia
关键词
High-grade ovarian cancer; lymph node metastasis; BMP2; BMP7; integrin alpha 5; integrin beta 1; ZEB2; EPITHELIAL-MESENCHYMAL TRANSITION; CANCER CELLS; GENE-EXPRESSION; BREAST-CANCER; TGF-BETA; BONE; INHIBITION; PROTEINS; SURVIVAL;
D O I
10.1080/08977194.2022.2099849
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Ovarian cancer (OC) is clinically important because it is diagnosed late and has metastasis when it is diagnosed. Mortality risk increases 2.75 times in the presence of lymph node (LN) metastasis. During metastasis, many molecules including BMPs originated from stroma, and tumor cells participate through transcription factors and integrins for cytoskeleton regulation during cell migration. We hypothesized an inverse correlation between BMP2 and BMP7 along with changes in ZEB2, and integrin alpha 5 beta 1 in high-grade OCs in relation to LN metastasis. The BMP2 immunoreactivity was strong along with strong ZEB2 and weak integrins' immunoreactivity in samples with LN metastasis. Strong immunoreactivity of BMP7 was accompanied by strong immunoreactivity of integrins in the samples without LN metastasis. Study results showed BMP2's strong positive immunoreactivity and weak BMP7 immunoreactivity in tumor cells with a significantly weak inverse correlation. This inverse correlation should be considered as both BMPs have different effects in the window of cancer progression and invasion.
引用
收藏
页码:153 / 162
页数:10
相关论文
共 50 条
  • [1] Increased Twist and ZEB2 expression in a cutaneous metastasis of high-grade glioma
    Nagaishi, Masaya
    Fujii, Yoshiko
    Sugiura, Yoshiki
    Takano, Issei
    Takigawa, Tomoji
    Yokoo, Hideaki
    Suzuki, Kensuke
    NEUROPATHOLOGY, 2020, 40 (02) : 196 - 201
  • [2] Differential expression of immune related genes in high-grade ovarian serous carcinoma
    Siamakpour-Reihani, Sharareh
    Cobb, Lauren Patterson
    Jiang, Chen
    Zhang, Dadong
    Previs, Rebecca A.
    Owzar, Kouros
    Nixon, Andrew B.
    Secord, Angeles Alvarez
    GYNECOLOGIC ONCOLOGY, 2020, 156 (03) : 662 - 668
  • [3] ZEB2 facilitates peritoneal metastasis by regulating the invasiveness and tumorigenesis of cancer stem-like cells in high-grade serous ovarian cancers
    Li, Yiying
    Fei, He
    Lin, Qiwang
    Liang, Fan
    You, Yanan
    Li, Ming
    Wu, Mengyao
    Qu, Ying
    Li, Pengfei
    Yuan, Yan
    Chen, Tong
    Jiang, Hua
    ONCOGENE, 2021, 40 (32) : 5131 - 5141
  • [4] Prognostic significance of differential expression of angiogenic genes in women with high-grade serous ovarian carcinoma
    Siamakpour-Reihani, Sharareh
    Owzar, Kouros
    Jiang, Chen
    Turner, Taylor
    Deng, Yiwen
    Bean, Sarah M.
    Horton, Janet K.
    Berchuck, Andrew
    Marks, Jeffrey R.
    Dewhirst, Mark W.
    Secord, Angeles Alvarez
    GYNECOLOGIC ONCOLOGY, 2015, 139 (01) : 23 - 29
  • [5] Axillary lymph-node metastases as the primary presentation of high-grade serous ovarian carcinoma: A case report
    Mirzaei, Monire
    Eshraghi, Abbas
    Ghoddoosi, Mahdiieh
    Fatemi, Maedeh Alsadat
    Eshraghi, Azhar
    Shenavaei, Sara
    Fazilat-panah, Danial
    CLINICAL CASE REPORTS, 2022, 10 (04):
  • [6] Preclinical 89Zr Immuno-PET of High-Grade Serous Ovarian Cancer and Lymph Node Metastasis
    Sharma, Sai Kiran
    Sevak, Kuntal K.
    Monette, Sebastien
    Carlin, Sean D.
    Knight, James C.
    Wuest, Frank R.
    Sale, Evis
    Zeglis, Brian M.
    Lewis, Jason S.
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (05) : 771 - 776
  • [7] Consensus on Molecular Subtypes of High-Grade Serous Ovarian Carcinoma
    Chen, Gregory M.
    Kannan, Lavanya
    Geistlinger, Ludwig
    Kofia, Victor
    Safikhani, Zhaleh
    Gendoo, Deena M. A.
    Parmigiani, Giovanni
    Birrer, Michael
    Haibe-Kains, Benjamin
    Waldron, Levi
    CLINICAL CANCER RESEARCH, 2018, 24 (20) : 5037 - 5047
  • [8] SPARC suppresses lymph node metastasis by regulating the expression of VEGFs in ovarian carcinoma
    Peng, Fenghui
    Zhong, Yanping
    Liu, Yunfeng
    Zhang, Yueming
    Xie, Yihong
    Lu, Yingxin
    Zhang, Xinyin
    Li, Danrong
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2017, 51 (06) : 1920 - 1928
  • [9] Clinical Outcomes of Patients with High-Grade Ovarian Carcinoma Arising in Endometriosis Compared to Ovarian High-Grade Serous Carcinoma
    Yalcin, Ibrahim
    Sahin, Hanifi
    Sari, Mustafa Erkan
    Haberal, Asuman Nihan
    Sahin, Eda Adeviye
    Celik, Husnu
    Meydanli, Mehmet Mutlu
    Ayhan, Ali
    INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2021, 19 (04)
  • [10] Akt2/ZEB2 may be a biomarker for exfoliant cells in ascitic fluid in advanced grades of serous ovarian carcinoma
    Liu, Changmei
    Yang, Fangmei
    TUMOR BIOLOGY, 2015, 36 (09) : 7213 - 7219